New Exec to Lead Cluster of Global Imaging Businesses at Philips Healthcare

Royal Philips has expanded its team of healthcare executives.

The company has appointed Robert Cascella to lead the company’s multi-billion euro cluster of Imaging businesses, succeeding Gene Saragnese, who is retiring from Philips as of May 1. Cascella will hold the title of executive vice president, Royal Philips.

Cascella joins Philips with more than 30 years of experience in the healthcare industry. He spent the previous 10 years at Hologic Inc., a developer women’s healthcare technology, where he was president and later CEO. During this period, Hologic broadly diversified its product portfolio and substantially grew revenues through a combination of product development and acquisitions, as well as the establishment of exceptionally strong customer relationships.

In his new role, Cascella will be CEO of the Business Group Diagnostic Imaging (MRI, CT, PET and X-Ray), while also overseeing the other two business groups in the cluster of imaging businesses: Image-Guided Therapy, which includes the recently acquired Volcano business, and Ultrasound. Cascella will be based in Andover, Mass., and Amsterdam (The Netherlands), and will report directly to Royal Philips CEO Frans van Houten. 

“Rob has an impressive track record in value creation in the healthcare industry, with a strong focus on integrated solutions,” van Houten said. “He will bring a wealth of expertise in diagnostic imaging, together with deep customer insights at a crucial time for Philips, as we accelerate our transformation in HealthTech and shape the future of the industry.”  

Commenting on his appointment, Mr. Cascella said: “I am absolutely thrilled to be joining Philips. The company’s tremendous history of innovation, its position in medical imaging and its customer-centric focus on the health tech opportunity will make it both an exciting and rewarding place to work. I look forward to contributing to its future success.”